nvista Holdings Corporation (NYSE: NVST) (“Envista”) will report financial results for its fourth quarter 2024 on Wednesday, February 5, 2025. Envista is moving the time of the conference call and will now discuss these results beginning at 2:30 PM PT on the same date. The call will last approximately one hour.
The call and the accompanying slide presentation will be webcast on the “Investors” section of Envista’s website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. You can access the conference call by dialing 800-225-9448 within the U.S. or +1 203-518-9708 outside the U.S. a few minutes before 2:30 PM PT and referencing conference ID #7185081.
Envista’s earnings press release, the webcast slides, and other related presentation materials will be posted to the “Investors” section of Envista’s website before the conference call and will remain available following the call.
About Envista Holdings Corporation
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services.
Its comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide range of dentists’ clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile.
With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry.
Source: www.envistaco.com
Periodontology 10 September 2025
To update the findings of a systematic review from the year 2016 on the evidence for the accuracy and potential benefits of cone beam computed tomography (CBCT) in periodontal diagnostics.
Oral carcinogenesis is a multifactorial process involving numerous genetic events that alter normal functions of oncogenes and tumour suppressor genes.
New surgical kits, a 6.0-mm implant, and upgraded accessories elevate the clinical ease and versatility of the company’s flagship system.
Oral surgery 24 May 2024
Dental autotransplantation (AT) is defined as the transplantation of a tooth from one site to a different site in the oral cavity of the same individual.
On Monday, February 5, 2024, the American Dental Association (ADA) updated their opioid prescribing guidelines for dental procedures in adults and adolescents (over 12 years of age.)
Periodontology 14 November 2025
This study was carried out to assess the oral hygiene awareness and practices amongst patients visiting the Department of Periodontology at Gian Sagar Dental College and Hospital, Ramnagar (Patiala).
Editorials 14 November 2025
Penn Dental Medicine shared its expertise in caring for persons with disabilities with dental care providers from throughout Jamaica at a 1 ½ -day hands-on continuing education program, held October...
News 14 November 2025
Dr. Thomas M. Paumier, a dentist in Canton, Ohio, is the new President-Elect of the American Dental Association (ADA). Dr. Paumier was elected at the ADA House of Delegates meeting in Washington,...
News 14 November 2025
Premier Dental Implants & Prosthodontics is proud to announce the opening of its newly renovated dental office and the launch of its new website
News 14 November 2025
Henry Schein One and AWS Collaborate to Transform Global Dentistry with Generative AI
Industry leaders join forces to bring advanced AI capabilities to dental technology platforms — redefining patient care, clinical efficiency, and practice performance worldwide